Improvement in cognitive function Independently of depression symptoms reduction reported with CANTAB tasks following treatment with the antidepressant drug Deloxetine
Posted on 20 August 2014
Greer and colleagues have reported that 12 weeks treatment with the antidepressant drug Deloxetine (a serotonin and noradrenaline reuptake inhibitor) improved cognition measured using the CANTAB task in patients with MDD with subjective reports of cognitive impairment.
Cambridge Cognition and Altreos Research Partners, Inc. join forces as FDA guidelines drive demand for Human Abuse Liability studies
Posted on 13 August 2014
Cambridge Cognition, the global leader in touchscreen cognitive assessments for clinical trials, has formed a scientific partnership with Altreos Research Partners, Inc., a leading provider of scientific, regulatory and operational input on abuse liability assessments.
Posted on 29 July 2014
A new study conducted by researchers at the University of North Carolina is to examine the effect of the omega-6 to omega-3 fatty acid ratio on age-related changes in executive functions in children and older adults.
Analysts estimate new Alzheimer's assessment could reduce UK dementia diagnostic costs by 40% and save the NHS £33m in next 7 years
Posted on 14 July 2014
Financial analysts estimate the new Alzheimer's assessment device could save the NHS a minimum of £33m over next 7 yrs.